Join the 200th Anniversary Celebration

Original Article

Pseudomonas aeruginosa and Serratia marcescens Contamination Associated with a Manufacturing Defect in Bronchoscopes

David L. Kirschke, M.D., Timothy F. Jones, M.D., Allen S. Craig, M.D., Patricia S. Chu, M.D., Glenda G. Mayernick, R.N., Jayesh A. Patel, M.D., and William Schaffner, M.D.

N Engl J Med 2003; 348:214-220January 16, 2003

Abstract

Background

Several outbreaks and pseudo-outbreaks of Pseudomonas aeruginosa and Serratia marcescens infections associated with bronchoscopy have been reported. We conducted an investigation of P. aeruginosa and S. marcescens isolates related to bronchoscopy at a community hospital.

Methods

We reviewed the records of all bronchoscopic procedures at the community hospital from July to October 2001. Environmental samples were obtained. Pulsed-field gel electrophoresis (PFGE) was performed on isolates of P. aeruginosa.

Results

From July 1 to October 31, 2001, 66 bronchoscopic procedures were performed in 60 patients, and 43 specimens were obtained for bacterial culture; 20 of the specimens (47 percent) were positive for P. aeruginosa. Six (30 percent) of the specimens that were positive for P. aeruginosa also yielded S. marcescens. All 20 P. aeruginosa isolates were associated with procedures performed with three of four new bronchoscopes from the same manufacturer. Contrary to manufacturing specifications, the biopsy-port caps on all four bronchoscopes were easily removable, and P. aeruginosa was cultured from the biopsy ports of the three implicated bronchoscopes. The PFGE patterns of P. aeruginosa isolates from the bronchoscopes, patients, and two environmental samples were indistinguishable. One patient was hospitalized with P. aeruginosa pneumonia 11 days after bronchoscopy. The manufacturer reported a design change instituted in 1997, and production problems may have resulted in the distribution of bronchoscopes that did not meet specifications.

Conclusions

We documented contamination of bronchoscopes with P. aeruginosa and S. marcescens and possible infection of patients at a community hospital as a result of the inadequate disinfection of bronchoscopes because of a manufacturing defect.

Media in This Article

Figure 1Number of Pseudomonas aeruginosa Isolates Associated with Bronchoscopy at a Community Hospital Each Week from July through October 2001.
Figure 2Bronchoscope.
Article

In addition to visual inspection of the airway, laser therapy, electrocautery, and placement of airway stents can now be done by means of flexible bronchoscopy1; approximately 500,000 bronchoscopic procedures are performed annually in the United States.2 One limitation to the use of bronchoscopes is that sterilization between procedures is not practical because autoclaving damages the instrument and ethylene oxide reprocessing requires an often unacceptable amount of time.3 Therefore, cleaning and high-level disinfection are routinely performed instead.4,5 However, even cleaning and disinfection have been a challenge because of the complex design of flexible bronchoscopes,6 prompting the publication of guidelines.7-11 Several bronchoscope-related outbreaks and pseudo-outbreaks of Pseudomonas aeruginosa and Serratia marcescens infection have been reported,12-17 all of which resulted from some breach of the cleaning and disinfection guidelines.9,11,18

In September 2001, an infection-control practitioner at a community hospital notified the Tennessee Department of Health of an increase in the number of P. aeruginosa and S. marcescens isolates associated with bronchoscopy. We report the results of the subsequent investigation.

Methods

We reviewed laboratory reports of all P. aeruginosa and S. marcescens isolates at the community hospital during 2001. A case was defined by the isolation of P. aeruginosa or S. marcescens from a specimen obtained during bronchoscopy in a patient at the community hospital from July 1 to October 31, 2001. We reviewed the endoscopy records, which included the serial numbers of the bronchoscopes used, for all patients who underwent bronchoscopy during this period. We reviewed the medical records of all patients who underwent bronchoscopy during the study period to determine whether any were readmitted for infections caused by P. aeruginosa or S. marcescens during the month after the procedure.

Environmental samples were obtained from the bronchoscopes and other sites within the endoscopy suite. Specimens were obtained from the bronchoscopes by flushing them with sterile saline or by using moistened swabs. Swab specimens were obtained from the automated endoscope reprocessor and items used during procedures. In addition, 100-ml specimens of liquids were collected, including source water, rinse water, and disinfectant used in the automated endoscope reprocessor and tap water and drain water from the cleaning sink. The hospital's endoscope-reprocessing procedures were reviewed, and the bronchoscopes were inspected.

Isolates of P. aeruginosa were compared with the use of pulsed-field gel electrophoresis (PFGE). Restriction-endonuclease digestion of bacterial chromosomes was performed with XbaI (New England Biolabs), and the relatedness of strains was examined with the use of Molecular Analyst software.19

We performed bivariate statistical analyses using chi-square tests calculated with Epi Info 2000 software.20

Results

The community hospital is a 203-bed facility with four pulmonologists who performed 267 bronchoscopy procedures in 2001. From July 1 to October 31, 2001, 66 bronchoscopic procedures were performed in 60 patients with eight different bronchoscopes owned by the hospital, and 43 specimens were obtained for bacterial culture. Of the 43 bacterial cultures, 20 specimens (47 percent) yielded P. aeruginosa. Six of the 20 specimens (30 percent) with P. aeruginosa also yielded S. marcescens.

Of the 20 patients with specimens positive for P. aeruginosa, 11 (55 percent) were male; the median age of these patients was 59 years (range, 24 to 88). Evaluation of pneumonia was the primary indication for bronchoscopy in the case of only four patients (20 percent). None of the 20 patients were discharged with a diagnosis of pneumonia caused by P. aeruginosa or S. marcescens.

Between July 1 and September 17, when the investigation began, four of the hospital's eight bronchoscopes had been used, but P. aeruginosa was isolated from specimens obtained from only two (bronchoscopes A and B). Both were new bronchoscopes of similar models (BF-1T160 and BF-160, respectively) produced by the same manufacturer (Olympus America).

Bronchoscopes A and B had been received by the hospital on July 11, just eight days before the collection of the first specimen that was positive for P. aeruginosa (Figure 1Figure 1Number of Pseudomonas aeruginosa Isolates Associated with Bronchoscopy at a Community Hospital Each Week from July through October 2001.). They were first used on July 13 and July 24, respectively, and specimens positive for P. aeruginosa were obtained by the time of the third procedure performed with either bronchoscope. Of the 16 specimens collected for bacterial culture from patients during bronchoscopy with bronchoscope A, 12 (75 percent) were positive for P. aeruginosa; 5 of 8 specimens (62 percent) collected from patients during bronchoscopy with bronchoscope B were positive for P. aeruginosa. Bronchoscopes A and B were removed from service on September 18, and no P. aeruginosa isolates were reported in specimens obtained during bronchoscopy during the following five weeks.

Inspection of bronchoscopes A and B revealed that the caps of the biopsy ports (Figure 2Figure 2Bronchoscope.) were not securely fastened and were easily removable, contrary to manufacturing specifications. The port caps were loose enough to be unscrewed with two fingers but not so loose that the problem was apparent to the bronchoscopy staff. When the threads of the biopsy ports and the inside of the caps of bronchoscopes A and B (Figure 3Figure 3Biopsy Port with Cap and Bushing Removed.) were swabbed, a dark green film was noted, and 9 of 12 swab specimens were positive for P. aeruginosa and S. marcescens. The other three swab specimens were positive for P. aeruginosa alone, including one specimen obtained after three cycles of cleaning and disinfection in the hospital's automated endoscope reprocessor.

On October 11, the community hospital received two new bronchoscopes (C and D) from the manufacturer, which were the same two models as bronchoscopes A and B. Bronchoscope C was used only twice. On reprocessing, it was noted that the biopsy-port cap was loose, and the bronchoscope was removed from service, but no specimen was collected from the biopsy port. P. aeruginosa was isolated from all three specimens collected for bacterial culture from patients who underwent bronchoscopy with bronchoscope D. The biopsy-port cap was found to be loose, and all five swab specimens of the biopsy-port cap yielded P. aeruginosa. Bronchoscope D was removed from service on October 31.

The four recent-model bronchoscopes with loose biopsy-port caps (bronchoscopes A, B, C, and D) were used for 40 procedures; 28 specimens were obtained for culture, and 20 were positive for P. aeruginosa (Table 1Table 1Risk of Infection with Pseudomonas aeruginosa Associated with the Use of Recent-Model Bronchoscopes, as Compared with Older-Model Bronchoscopes.). We compared these bronchoscopes with four older-model bronchoscopes by the same manufacturer (bronchoscopes E, F, G, and H) that were in use during the study period and that were never noted to have loose or removable biopsy-port caps (Table 1). The risk that a specimen would be positive for P. aeruginosa was associated only with the use of recent-model bronchoscopes with the loose biopsy-port caps (P<0.001).

The bronchoscopy-associated strain of P. aeruginosa was resistant only to gentamicin. Isolates of P. aeruginosa from 10 patients were available for PFGE; no S. marcescens isolates were available. The P. aeruginosa isolates from all 10 patients and from the biopsy-port caps of bronchoscopes A, B, and D were indistinguishable on PFGE (Figure 4Figure 4Results of Pulsed-Field Gel Electrophoresis Demonstrating the Clonal Pattern of Isolates from Five Patients and Three Bronchoscopes.).

A total of 113 environmental samples were collected within the bronchoscopy suite; 61 were from bronchoscopes and 52 were from other environmental sources. Of the 52 environmental samples, 2 specimens (4 percent) were positive for P. aeruginosa. Both were from the sink trap where the bronchoscopes were rinsed before being placed in the automated endoscope reprocessor. The PFGE patterns of the two environmental isolates matched the bronchoscopy-associated strain.

The bronchoscopes were routinely processed in an automated endoscope reprocessor (model MV-2, MediVators) with use of a 0.55 percent solution of ortho-phthalaldehyde (Cidex OPA, Advanced Sterilization Products). A representative of the manufacturer of the automated endoscope reprocessor reviewed the hospital's reprocessing procedures and indicated that they were satisfactory, except that the source water filter for the reprocessor had not been changed within the recommended six months. No strains of P. aeruginosa were isolated from either the source water or the filter.

A 50-year-old woman was readmitted 11 days after bronchoscopy with new pulmonary infiltrates in the right middle lobe. The specimen obtained during bronchoscopy was positive for P. aeruginosa. On readmission, she had fever, leukocytosis, dyspnea, and increasing cough with darkening sputum. Culture of a sputum sample yielded P. aeruginosa with an antibiotic-susceptibility pattern similar to that of the epidemic strain. No isolates were available for PFGE. The pneumonia resolved.

Discussion

A striking increase in the number of isolates of P. aeruginosa and S. marcescens from bronchoscopy specimens occurred at a community hospital from July through October 2001. One bronchoscopy-associated case of P. aeruginosa pneumonia was identified. The likelihood of positivity for P. aeruginosa or S. marcescens was associated only with the use of recent-model bronchoscopes that had loose biopsy-port caps. Strains of P. aeruginosa and S. marcescens were isolated from the biopsy ports of the implicated bronchoscopes. PFGE patterns linked the P. aeruginosa isolates from the patients to the isolates from the bronchoscopes.

Because the risk of a specimen's being positive for P. aeruginosa or S. marcescens was associated exclusively with the use of the recent-model bronchoscopes with the loose biopsy-port caps and because a case of bronchoscopy-associated pneumonia was identified, the manufacturer and the Food and Drug Administration were notified on September 18 and October 8, respectively. At that time, the Centers for Disease Control and Prevention indicated that no related outbreaks had been reported.

In 1997, the manufacturer changed the design of the biopsy port on at least 15 models of bronchoscopes that were still in use in 2001. Part of the new design involved changing the biopsy-port housing to a removable cap that was screwed on but fixed with adhesive. The manufacturer reported that failure to conform to production standards resulted in the distribution of bronchoscopes that did not meet manufacturing specifications. This might explain why problems with these models of bronchoscopes had not been reported previously. An alternative explanation is that infectious complications related to bronchoscopes often go unrecognized or unreported.9,21-23

Persistent bacterial contamination of the biopsy port was probably not a result of a breach of the cleaning and disinfection guidelines, because the hospital's reprocessing procedures were determined to be satisfactory. In addition, contamination persisted even after three cycles of cleaning and disinfection in the automated reprocessor, and other bronchoscopes in use during the study period were not associated with positive cultures.

The loose biopsy-port caps most likely interfered with three important steps in reprocessing performed according to the current guidelines: mechanical cleaning, high-level disinfection, and drying.7 Mechanical cleaning is necessary to remove the biofilm that can interfere with disinfection.24,25 Contaminated surfaces inside the hollow biopsy-port caps could not be cleaned mechanically. High-level disinfection requires an approved disinfectant to be in contact with a contaminated surface for a specified period of time.26 The loose biopsy-port caps, which probably had air pockets when submerged, might have prevented effective contact between the disinfectant and the microorganisms. Finally, drying is recommended to prevent the growth of microorganisms with a predilection for moist environments.27 The design of the caps probably prevented thorough drying of surfaces inside the caps.

The origin of the contaminating bacteria remains elusive. One postulated sequence of events is that the loose biopsy-port caps were contaminated in the sink when the bronchoscopes were cleaned before being placed in the automated endoscope reprocessor. Once within the biopsy-port caps, the bacteria were protected from the chemical-disinfection process. During subsequent use of the bronchoscopes, sterile saline was flushed through the biopsy ports, thereby becoming contaminated and further contaminating the bronchoscope channels and the patients' lower respiratory tracts. The contaminated lavage specimens were then suctioned back through the bronchoscope channels by means of the suction ports and collected for bacterial culture, yielding false positive results.

Antibiotic therapy was initiated in five patients (25 percent) after false positive culture results were reported. If these results reflected contaminated bronchoscopes rather than actual infections, the patients may have received unnecessary antibiotic treatment. Conversely, if patients were infected during the bronchoscopic procedures, the antibiotics may have prevented nosocomial illnesses.

After receiving our report, the manufacturer of the bronchoscopes initiated a recall of certain models. The voluntary recall, issued on November 30, 2001, affected 15 models of bronchoscopes, including the 2 models implicated in this investigation. The stated purpose was “to address a potential looseness of the biopsy-channel port housing [cap].” The recall reportedly involved an estimated 4700 bronchoscopes nationwide and was later expanded to include approximately 14,000 bronchoscopes worldwide. The manufacturer proposed modifying the bronchoscopes to resolve the problem with the caps. The recall received national media attention after an outbreak associated with the recalled models of bronchoscopes was reported at a hospital in another state, as described by Srinivasan et al.28 Further microbiologic and epidemiologic surveillance is warranted to ensure that bronchoscopes modified as a result of the recall are not associated with further cases of false positive clinical specimens or infections.

We are indebted to Henrietta Hardin and the Tennessee Department of Health State Laboratory staff; to Patricia Coleman, Lynn King, and the community hospital pulmonologists and endoscopy staff; to Nita Lamb and the Vanderbilt University Medical Center infection-control practitioners for consultation and advice; to Walter E. Phillips, Ph.D.; and to Laura J. Fehrs, M.D.

Source Information

From the Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta (D.L.K.); the Tennessee Department of Health, Nashville (D.L.K., T.F.J., A.S.C.); the Vanderbilt University School of Medicine, Nashville (T.F.J., A.S.C., P.S.C., W.S.); and Skyline Medical Center, Nashville (G.G.M., J.A.P.).

Address reprint requests to Dr. Schaffner at the Vanderbilt University School of Medicine, Medical Center North, Rm. A-1124, Nashville, TN 37232, or at .

References

References

  1. 1

    Seijo LM, Sterman DH. Interventional pulmonology. N Engl J Med 2001;344:740-749
    Full Text | Web of Science | Medline

  2. 2

    Owings MF, Kozak LJ. Ambulatory and inpatient procedures in the United States, 1996. Vital and health statistics. Series 13. No. 139. Hyattsville, Md.: National Center for Health Statistics, November 1998. (DHHS publication no. (PHS) 99-1710.)

  3. 3

    Favero MS, Bond WW. Chemical disinfection of medical and surgical materials. In: Block SS, ed. Disinfection, sterilization, and preservation. 4th ed. Philadelphia: Lea & Febiger, 1991:617-40.

  4. 4

    Rutala WA, Weber DJ. Disinfection of endoscopes: review of new chemical sterilants used for high-level disinfection. Infect Control Hosp Epidemiol 1999;20:69-76[Erratum, Infect Control Hosp Epidemiol 1999;20:302.]
    CrossRef | Web of Science | Medline

  5. 5

    Muscarella LF. High-level disinfection or “sterilization“ of endoscopes? Infect Control Hosp Epidemiol 1996;17:183-187
    CrossRef | Web of Science | Medline

  6. 6

    Bond WW. Endoscopy reprocessing: problems and solutions. In: Rutala WA, ed. Disinfection, sterilization and antisepsis in health care. Washington, D.C.: Association for Professionals in Infection Control and Epidemiology, 1998:151-63.

  7. 7

    Alvarado CJ, Reichelderfer M. APIC guideline for infection prevention and control in flexible endoscopy. Am J Infect Control 2000;28:138-155
    CrossRef | Web of Science | Medline

  8. 8

    Feigal DW Jr, Hughes JM. FDA and CDC public health advisory: infections from endoscopes inadequately reprocessed by an automated endoscope reprocessing system. Rockville, Md.: Food and Drug Administration, Center for Devices and Radiological Health, September 10, 1999. (Also available at http://www.fda.gov/cdrh/safety/endoreprocess.html.)

  9. 9

    Spach DH, Silverstein FE, Stamm WE. Transmission of infection by gastrointestinal endoscopy and bronchoscopy. Ann Intern Med 1993;118:117-128
    Web of Science | Medline

  10. 10

    Prakash UB. Does the bronchoscope propagate infection? Chest 1993;104:552-559
    CrossRef | Web of Science | Medline

  11. 11

    Ostrowsky B. Endoscopes -- current practices and controversies in infection control. Semin Infect Control 2001;1:267-279

  12. 12

    Sorin M, Segal-Maurer S, Mariano N, Urban C, Combest A, Rahal JJ. Nosocomial transmission of imipenem-resistant Pseudomonas aeruginosa following bronchoscopy associated with improper connection to the Steris System 1 processor. Infect Control Hosp Epidemiol 2001;22:409-413
    CrossRef | Web of Science | Medline

  13. 13

    Blanc DS, Parret T, Janin B, Raselli P, Francioli P. Nosocomial infections and pseudoinfections from contaminated bronchoscopes: two-year follow up using molecular markers. Infect Control Hosp Epidemiol 1997;18:134-136
    CrossRef | Web of Science | Medline

  14. 14

    Sammartino MT, Israel RH, Magnussen CR. Pseudomonas aeruginosa contamination of fibreoptic bronchoscopes. J Hosp Infect 1982;3:65-71
    CrossRef | Medline

  15. 15

    Kolmos HJ, Lerche A, Kristoffersen K, Rosdahl VT. Pseudo-outbreak of Pseudomonas aeruginosa in HIV-infected patients undergoing fiberoptic bronchoscopy. Scand J Infect Dis 1994;26:653-657
    CrossRef | Web of Science | Medline

  16. 16

    Vandenbroucke-Grauls CM, Baars AC, Visser MR, Hulstaert PF, Verhoef J. An outbreak of Serratia marcescens traced to a contaminated bronchoscope. J Hosp Infect 1993;23:263-270
    CrossRef | Web of Science | Medline

  17. 17

    Siegman-Igra Y, Inbar G, Campus A. An `outbreak' of pulmonary pseudoinfection by Serratia marcescens. J Hosp Infect 1985;6:218-220
    CrossRef | Web of Science | Medline

  18. 18

    Weber DJ, Rutala WA. Lessons from outbreaks associated with bronchoscopy. Infect Control Hosp Epidemiol 2001;22:403-408
    CrossRef | Web of Science | Medline

  19. 19

    Molecular Analyst software, version 1.6. Hercules, Calif.: BioRad Laboratories, 1992.

  20. 20

    Dean AG, Arner TG, Sangam S, et al. Epi Info 2000, version 1.1: a database and statistics program for public health professionals for use on Windows 95, 98, NT, and 2000 computers. Atlanta: Centers for Disease Control and Prevention, 2001.

  21. 21

    Bronchoscopy-related infections and pseudoinfections -- New York, 1996 and 1998. MMWR Morb Mortal Wkly Rep 1999;48:557-560
    Medline

  22. 22

    Wheeler PW, Lancaster D, Kaiser AB. Bronchopulmonary cross-colonization and infection related to mycobacterial contamination of suction valves of bronchoscopes. J Infect Dis 1989;159:954-958
    CrossRef | Web of Science | Medline

  23. 23

    Michele TM, Cronin WA, Graham NM, et al. Transmission of Mycobacterium tuberculosis by a fiberoptic bronchoscope: identification by DNA fingerprinting. JAMA 1997;278:1093-1095
    CrossRef | Web of Science | Medline

  24. 24

    Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 1998;280:295-298
    CrossRef | Web of Science | Medline

  25. 25

    Kolter R, Losick R. One for all and all for one. Science 1998;280:226-227
    CrossRef | Web of Science | Medline

  26. 26

    Rutala WA, Gergen MF, Weber DJ. Comparative evaluation of the sporicidal activity of new low-temperature sterilization technologies: ethylene oxide, 2 plasma sterilization systems, and liquid peracetic acid. Am J Infect Control 1998;26:393-398
    CrossRef | Web of Science | Medline

  27. 27

    Muscarella LF. Deja vu . . . all over again? The importance of instrument drying. Infect Control Hosp Epidemiol 2000;21:628-629
    CrossRef | Web of Science | Medline

  28. 28

    Srinivasan A, Wolfenden LL, Song X, et al. An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes. N Engl J Med 2002;348:221-227
    Full Text | Web of Science

Citing Articles (42)

Citing Articles

  1. 1

    David J. Weber, William A. Rutala. (2012) Lessons Learned From Outbreaks and Pseudo-Outbreaks Associated with Bronchoscopy. Infection Control and Hospital Epidemiology 33:3, 230-234
    CrossRef

  2. 2

    Sara E. Cosgrove, Polly Ristaino, Anne Caston-Gaa, Donna P. Fellerman, Elaine F. Nowakowski, Karen C. Carroll, Trish M. Perl, Lisa L. Maragakis. (2012) Caveat Emptor: The Role of Suboptimal Bronchoscope Repair Practices by a Third-Party Vendor in a Pseudo-Outbreak of Pseudomonas in Bronchoalveolar Lavage Specimens. Infection Control and Hospital Epidemiology 33:3, 224-229
    CrossRef

  3. 3

    Prasoon Jain, Atul C. Mehta. 2012. Infection Control and Radiation Safety in the Bronchoscopy Suite. , 6-31.
    CrossRef

  4. 4

    Sarah Tschudin-Sutter, Reno Frei, Günter Kampf, Michael Tamm, Eric Pflimlin, Manuel Battegay, Andreas Franz Widmer. (2011) Emergence of Glutaraldehyde-Resistant Pseudomonas aeruginosa. Infection Control and Hospital Epidemiology 32:12, 1173-1178
    CrossRef

  5. 5

    Sonja Hansen, Ralf-Peter Vonberg. 2011. Pathogen Transmission in the Healthcare Setting. , 23-38.
    CrossRef

  6. 6

    Bryan Corrin, Andrew G. Nicholson. 2011. Infectious diseases. , 155-262.
    CrossRef

  7. 7

    Alphi Elackattu, Mary Zoccoli, Jeffrey H. Spiegel, Kenneth M. Grundfast. (2010) A comparison of two methods for preventing cross-contamination when using flexible fiberoptic endoscopes in an otolaryngology clinic: Disposable sterile sheaths versus immersion in germicidal liquid. The Laryngoscope 120:12, 2410-2416
    CrossRef

  8. 8

    S. Gatermann, I.F. Chaberny, M. Pletz, B. Schaaf. (2010) Multiresistente pulmonale Erreger auf der Intensivstation. Der Pneumologe 7:6, 412-422
    CrossRef

  9. 9

    A.E. Muller, I. Huisman, P.J. Roos, A.P. Rietveld, J. Klein, J.B.M. Harbers, J.J. Dorresteijn, J.E. van Steenbergen, M.C. Vos. (2010) Outbreak of severe sepsis due to contaminated propofol: lessons to learn. Journal of Hospital Infection 76:3, 225-230
    CrossRef

  10. 10

    Yoko Ogushi, Hiroshi Eguchi, Tomomi Kuwahara, Naoko Hayabuchi, Masako Kawabata. (2010) Molecular genetic investigations of contaminated contact lens storage cases as reservoirs of Pseudomonas aeruginosa Keratitis. Japanese Journal of Ophthalmology 54:6, 550-554
    CrossRef

  11. 11

    Steven M. Zinder, Rodney S. W. Basler, Jack Foley, Chris Scarlata, David B. Vasily. (2010) National Athletic Trainers' Association Position Statement: Skin Diseases. Journal of Athletic Training 45:4, 411-428
    CrossRef

  12. 12

    A. Kohlenberg, D. Weitzel-Kage, P. van der Linden, D. Sohr, S. Vögeler, A. Kola, E. Halle, H. Rüden, K. Weist. (2010) Outbreak of carbapenem-resistant Pseudomonas aeruginosa infection in a surgical intensive care unit. Journal of Hospital Infection 74:4, 350-357
    CrossRef

  13. 13

    S. Buffet-Bataillon, V. Rabier, P. Bétrémieux, A. Beuchée, M. Bauer, P. Pladys, E. Le Gall, M. Cormier, A. Jolivet-Gougeon. (2009) Outbreak of Serratia marcescens in a neonatal intensive care unit: contaminated unmedicated liquid soap and risk factors. Journal of Hospital Infection 72:1, 17-22
    CrossRef

  14. 14

    Claire E. Wainwright, Keith Grimwood, John B. Carlin, Suzanna Vidmar, Peter J. Cooper, Paul W. Francis, Catherine A. Byrnes, Bruce F. Whitehead, A. James Martin, Ian F. Robertson, David M. Cooper, Carolyn J. Dakin, Ian. B. Masters, R. John Massie, Philip J. Robinson, Sarath Ranganathan, David S. Armstrong, Lyndall K. Patterson, Colin F. Robertson. (2008) Safety of bronchoalveolar lavage in young children with cystic fibrosis. Pediatric Pulmonology 43:10, 965-972
    CrossRef

  15. 15

    Constanze Wendt, Birgit Kampf. (2008) Evidence-based spectrum of antimicrobial activity for disinfection of bronchoscopes. Journal of Hospital Infection 70, 60-68
    CrossRef

  16. 16

    R. Howie, M.J. Alfa, K. Coombs. (2008) Survival of enveloped and non-enveloped viruses on surfaces compared with other micro-organisms and impact of suboptimal disinfectant exposure. Journal of Hospital Infection 69:4, 368-376
    CrossRef

  17. 17

    Elizabeth E Gillespie, Despina Kotsanas, Rhonda L Stuart. (2008) Microbiological monitoring of endoscopes: 5-year review. Journal of Gastroenterology and Hepatology 23:7pt1, 1069-1074
    CrossRef

  18. 18

    Adam L. Cohen, Alison Ridpath, Judith Noble-Wang, Bette Jensen, Alicia M. Peterson, Matt Arduino, Dan Jernigan, Arjun Srinivasan. (2008) Outbreak of Serratia marcescens Bloodstream and Central Nervous System Infections After Interventional Pain Management Procedures. The Clinical Journal of Pain 24:5, 374-380
    CrossRef

  19. 19

    O. Leiß, L. Bader, M. Mielke, M. Exner. (2008) Fünf Jahre Empfehlungen der Kommission für Krankenhaushygiene zur Aufbereitung flexibler Endoskope. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 51:2, 211-220
    CrossRef

  20. 20

    Jane D. Siegel, Emily Rhinehart, Marguerite Jackson, Linda Chiarello. (2007) 2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings. American Journal of Infection Control 35:10, S65-S164
    CrossRef

  21. 21

    Jane D. Siegel, Emily Rhinehart, Marguerite Jackson, Linda Chiarello. (2007) Management of multidrug-resistant organisms in health care settings, 2006. American Journal of Infection Control 35:10, S165-S193
    CrossRef

  22. 22

    Shang-Chen Hsieh, Chia-Chen Lu, Yu-Tze Horng, Po-Chi Soo, Yung-Lin Chang, Yu-Huan Tsai, Chuan-Sheng Lin, Hsin-Chih Lai. (2007) The bacterial metabolite 2,3-butanediol ameliorates endotoxin-induced acute lung injury in rats. Microbes and Infection 9:12-13, 1402-1409
    CrossRef

  23. 23

    Adam M. Bressler, Keith S. Kaye, John J. LiPuma, Barbara D. Alexander, Christopher M. Moore, L. Barth Reller, Christopher W. Woods. (2007) Risk Factors for Burkholderia cepacia Complex Bacteremia Among Intensive Care Unit Patients Without Cystic Fibrosis: A Case‐Control Study • . Infection Control and Hospital Epidemiology 28:8, 951-958
    CrossRef

  24. 24

    U. Kircheis, H. Martiny. (2007) Comparison of the cleaning and disinfecting efficacy of four washer-disinfectors for flexible endoscopes. Journal of Hospital Infection 66:3, 255-261
    CrossRef

  25. 25

    Jesús Molina-Cabrillana, Juan Carlos Rodríguez-Bermejo, Cristóbal del Rosario-Quintana, Margarita Bolaños-Rivero. (2007) Rápida detección de un brote de colonización por Serratia marcescens asociado a broncoscopias. Enfermedades Infecciosas y Microbiología Clínica 25:3, 222-224
    CrossRef

  26. 26

    William A. Rutala, David J. Weber. (2007) How to Assess Risk of Disease Transmission to Patients When There Is a Failure to Follow Recommended Disinfection and Sterilization Guidelines • . Infection Control and Hospital Epidemiology 28:2, 146-155
    CrossRef

  27. 27

    Enrique Seoane-Vazquez, Rosa Rodriguez-Monguio, Jay Visaria, Angeline Carlson. (2006) Exogenous endoscopy-related infections, pseudo-infections, and toxic reactions: clinical and economic burden. Current Medical Research and Opinion 22:10, 2007-2021
    CrossRef

  28. 28

    R. Bou, A. Aguilar, J. Perpiñán, P. Ramos, M. Peris, L. Lorente, A. Zúñiga. (2006) Nosocomial outbreak of Pseudomonas aeruginosa infections related to a flexible bronchoscope. Journal of Hospital Infection 64:2, 129-135
    CrossRef

  29. 29

    Angelo Pan, Lucia Dolcetti, Catia Barosi, Patrizia Catenazzi, Tomaso Ceruti, Lucio Ferrari, Silvia Magri, Eugenia Quiros Roldan, Laura Soavi, Giuseppe Carnevale. (2006) An Outbreak of Serratia marcescens Bloodstream Infections Associated With Misuse of Drug Vials in a Surgical Ward • . Infection Control and Hospital Epidemiology 27:1, 79-83
    CrossRef

  30. 30

    P. Corne, S. Godreuil, H. Jean-Pierre, O. Jonquet, J. Campos, E. Jumas-Bilak, Sylvie Parer, H. Marchandin. (2005) Unusual implication of biopsy forceps in outbreaks of Pseudomonas aeruginosa infections and pseudo-infections related to bronchoscopy. Journal of Hospital Infection 61:1, 20-26
    CrossRef

  31. 31

    J.-C. Cêtre, M.-C. Nicolle, H. Salord, M. Pérol, S. Tigaud, G. David, M. Bourjault, P. Vanhems. (2005) Outbreaks of contaminated broncho-alveolar lavage related to intrinsically defective bronchoscopes. Journal of Hospital Infection 61:1, 39-45
    CrossRef

  32. 32

    Stephen R. Gorman, John F. Beamis. (2005) Complications of Flexible Bronchoscopy. Clinical Pulmonary Medicine 12:3, 177-183
    CrossRef

  33. 33

    Maha Almuneef, Ziad A. Memish, Hanan H. Balkhy, Hala Alalem, Abdulrahman Abutaleb. (2004) Ventilator‐Associated Pneumonia in a Pediatric Intensive Care Unit in Saudi Arabia: A 30‐Month Prospective Surveillance • . Infection Control and Hospital Epidemiology 25:9, 753-758
    CrossRef

  34. 34

    Jean Carlet, Adel Ben Ali, Annie Chalfine. (2004) Epidemiology and control of antibiotic resistance in the intensive care unit. Current Opinion in Infectious Diseases 17:4, 309-316
    CrossRef

  35. 35

    W.A Rutala, D.J Weber. (2004) Reprocessing endoscopes: United States perspective. Journal of Hospital Infection 56, 27-39
    CrossRef

  36. 36

    Lawrence F. Muscarella. (2004) Contribution of Tap Water and Environmental Surfaces to Nosocomial Transmission of Antibiotic‐Resistant Pseudomonas aeruginosa • . Infection Control and Hospital Epidemiology 25:4, 342-345
    CrossRef

  37. 37

    Arjun Srinivasan. (2003) Epidemiology and prevention of infections related to endoscopy. Current Infectious Disease Reports 5:6, 467-472
    CrossRef

  38. 38

    NALINI SINGH, OZLEM BELEN, MARIE-MICHÈLE LÉGER, JOSEPH M. CAMPOS. (2003) Cluster of Trichosporon mucoides in children associated with a faulty bronchoscope. The Pediatric Infectious Disease Journal 22:7, 609-612
    CrossRef

  39. 39

    (2003) Outbreaks of Infection Associated with Bronchoscopes. New England Journal of Medicine 348:20, 2039-2040
    Full Text

  40. 40

    Udaya B.S. Prakash. (2003) The Perils of Contaminated Bronchoscopes. Journal of Bronchology 10:2, 97-98
    CrossRef

  41. 41

    Feigal, David W., Gardner, Susan N., McClellan, Mark, . (2003) Ensuring Safe and Effective Medical Devices. New England Journal of Medicine 348:3, 191-192
    Full Text

  42. 42

    Srinivasan, Arjun, Wolfenden, Linda L., Song, Xiaoyan, Mackie, Karen, Hartsell, Theresa L., Jones, Heather D., Diette, Gregory B., Orens, Jonathan B., Yung, Rex C., Ross, Tracy L., Merz, William, Scheel, Paul J., Haponik, Edward F., Perl, Trish M., . (2003) An Outbreak of Pseudomonas aeruginosa Infections Associated with Flexible Bronchoscopes. New England Journal of Medicine 348:3, 221-227
    Full Text

Letters